The European Huntington’s Disease Network, EHDN, held a clinical research congress in Kraków on 22-24 October 2026.
This was the largest congress ever for EHDN with over 1300 participants. The programme included an overview of the development of clinical therapies, the family and patient perspective of HD, lectures on genetic testing, update on ongoing research and clinical trials and much more.
TNU was represented by Åsa Petersén, Deputy Chair of the EHDN Executive Committee, Sofia Bergh, Jennifer Oraha and Karin Dalene Skarping. Members from the clinical team at the Huntington Clinic at Skåne University Hospital in Lund were also attending the congress.
Sofia Bergh presented her poster Decoupling somatic expansion from neuropathology in AAV vector-based mouse models with loss-of-interruption and duplication-of-interruption HTT variants in Kraków, Jennifer Oraha presented the poster Pathology of the emotion-and metabolism regulating ventromedial hypothalamus in Amyotrophic lateral sclerosis and Huntington disease and Isak Halling, neuropsychologist at the Huntington Clinic and involved in the ongoing clinical research study, presented the poster The Social-HD study: A cross-sectional observational study of social cognition in early Huntington disease.
Visit the EHDN webpage: https://ehdn.org/ehdn2026/ (opens in a new window)
